1. Agarwal, A., Sayres, L. C., Cho, M. K., Cook-Deegan, R., & Chandrasekharan, S. (2013). Commercial landscape of noninvasive prenatal testing in the United States. Prenatal Diagnosis, 33, 521–531.
2. Alexander, E., Kelly, S., & Kerzin-Storrar, L. (2015). Non-invasive prenatal testing: UK genetic counselors’ experiences and perspectives. Journal of Genetic Counseling, 24, 300–311.
3. Allyse, M. A., Sayres, L. C., Havard, M., King, J. S., Greely, H. T., Hudgins, L., Taylor, J., Norton, M. E., Cho, M. K., Magnus, D., & Ormond, K. E. (2013). Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing. Prenatal Diagnosis, 33, 656–661.
4. American College of Obstetrics and Gynecologists and Society for Maternal Fetal Medicine. (2017). Practice bulletin no. 163: screening for fetal aneuploidy. Obstetrics & Gynecology, 127, e123–e137.
5. Benn, P., & Chapman, A. R. (2016). Ethical and practical challenges in providing noninvasive prenatal testing for chromosome abnormalities: an update. Current Opinion in Obstetrics & Gynecology, 28, 119–124.